Find An Appointment
Request an Appointment With:
Julio J. Hajdenberg, MD
Hematology & Oncology
A representative will be in touch with you shortly to confirm your appointment. You should also receive an email confirming your appointment.
If you chose to be called, you may be asked for more information, so please have your insurance information ready.
Do you need to speak with someone regarding your appointment request? Call us at 321.843.2584
Orlando Health UF Health Cancer Center
Address: 1400 South Orange Avenue
Orlando, FL 32806
Julio Hajdenberg, MD, serves as chairman of the Department of Medical Oncology and Hematology as well as the section leader for Genitourinary Oncology and Nonmalignant Hematology at Orlando Health UF Health Cancer Center.
Dr. Hajdenberg joined Orlando Health UF Health Cancer Center in 2004. He is board-certified in internal medicine, medical oncology and hematology. He currently holds academic appointments at the University of Central Florida College of Medicine and Florida State University College of Medicine.
Fluent in Spanish, Dr. Hajdenberg received his medical degree from the Universidad de Buenos Aires in Buenos Aires, Argentina. He completed his medical internship and residency at the University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School. He fulfilled a fellowship in hematology and oncology at Harvard Medical School in Boston, where he served as a clinical instructor.
Dr. Hajdenberg received training awards from the American Association for Cancer Research and American Society of Clinical Oncology. He is a fellow with the American College of Physicians, and a member of the American Society of Hematology and the American Society of Clinical Oncology. He has served on the board of the Florida Society of Clinical Oncology.
His clinical research interests include cancers of the prostate, kidney and bladder, as well as some hematological neoplasms, such as lymphomas, Hodgkin's disease and chronic leukemias. He serves as the principal investigator on multiple cancer clinical trials involving those conditions.